Aditxt (ADTX) News Today $0.20 +0.01 (+3.78%) (As of 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Declines By 45.2%December 29 at 8:59 AM | americanbankingnews.comAditxt Advances ADI-100 Therapy to Human TrialsDecember 12, 2024 | tipranks.comAditxt extends merger agreement end date to January 2025November 21, 2024 | investing.comAppili Therapeutics shareholders vote in favor of Aditxt transactionNovember 14, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comAditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of SharesNovember 8, 2024 | finance.yahoo.comAditxt, Inc. Focuses on Growth Amid Nasdaq ComplianceNovember 6, 2024 | markets.businessinsider.comAditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary AdifemNovember 6, 2024 | businesswire.comEvofem Secures Investor Support for Proposed Merger through Voting AgreementsNovember 6, 2024 | prnewswire.comAditxt (NASDAQ:ADTX) Stock, Earnings Estimates, EPS, And RevenueOctober 16, 2024 | benzinga.comAditxt CEO Clarifies NASDAQ Compliance and Capital StrategyOctober 13, 2024 | finance.yahoo.comAditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight TimeOctober 9, 2024 | businesswire.comAditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With EvofemOctober 8, 2024 | finance.yahoo.comAditxt gears up for strategic acquisitions and Nasdaq complianceOctober 6, 2024 | uk.investing.comAditx Therapeutics Inc (ADTX)September 29, 2024 | investing.comAmazon staff threaten mass exodus following WFH banSeptember 27, 2024 | au.finance.yahoo.comAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024September 27, 2024 | businesswire.comAditxt's Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025September 20, 2024 | businesswire.comAppili Therapeutics Inc.: Appili Therapeutics Announces Results of Annual and Special Meeting of ShareholdersSeptember 18, 2024 | finanznachrichten.deInvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Seeks Grant Funding to Advance Early Detection, Management of Prostate CancerSeptember 5, 2024 | msn.comInvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Announces Participation at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 29, 2024 | msn.comAditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024August 29, 2024 | businesswire.comEvofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral SolutionAugust 20, 2024 | prnewswire.comBioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company UpdateAugust 14, 2024 | msn.comAditxt shareholders approve strategic proposalsAugust 14, 2024 | investing.comAditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders' Meeting, Setting the Stage for 2024 and 2025 Strategic PlansAugust 14, 2024 | stockhouse.comEvofem Biosciences Announces Financial Results for the Second Quarter of 2024August 14, 2024 | prnewswire.comAditxt swaps pre-funded warrants for preferred stock and new warrantsAugust 10, 2024 | uk.investing.comAditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 9, 2024 | businesswire.comAditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 9, 2024 | businesswire.comAditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian CancerAugust 7, 2024 | stockhouse.comBiotech Soars Despite Broader SelloffAugust 7, 2024 | msn.comFCA makes first crypto-related sting against Coinbase subsidiaryJuly 25, 2024 | uk.finance.yahoo.comEvofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stJuly 25, 2024 | globenewswire.comEvofem Signs Phexxi® License Agreement for Middle East with Pharma 1July 23, 2024 | prnewswire.comWhat's Going On With Aditxt Shares Wednesday?July 19, 2024 | msn.comWhy Is Aditxt (ADTX) Stock Up 72% Today!July 17, 2024 | investorplace.comLupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSECJuly 15, 2024 | prnewswire.comHello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareJune 27, 2024 | prnewswire.comEvofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of MatterJune 11, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | finanznachrichten.deEvofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | prnewswire.comAditxt secures $4.2 million in private placementMay 5, 2024 | investing.comCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesMay 3, 2024 | finance.yahoo.comAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesMay 3, 2024 | businesswire.comAditxt to Buy Biopharmaceutical Company Appili Therapeutics for Undisclosed AmountApril 2, 2024 | marketwatch.comAppili Therapeutics To Be Acquired By AditxtApril 2, 2024 | markets.businessinsider.comTrading was temporarily halted for "ADTX" at 09:04 AM with a stated reason of "LULD pause."April 2, 2024 | marketbeat.comAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)April 2, 2024 | businesswire.comEvofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023March 27, 2024 | finanznachrichten.de Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now ADTX Media Mentions By Week ADTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADTX News Sentiment▼1.360.59▲Average Medical News Sentiment ADTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADTX Articles This Week▼71▲ADTX Articles Average Week Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vincerx Pharma News Orgenesis News NLS Pharmaceutics News BioCardia News PHAXIAM Therapeutics News Bright Green News Kiora Pharmaceuticals News Aytu BioPharma News Cyclerion Therapeutics News Talphera News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADTX) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
